Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

被引：0
|
作者：
Michael V. Chiorean
Jessica R. Allegretti
Puza P. Sharma
Benjamin Chastek
Leonardo Salese
Elizabeth J. Bell
Jesse Peterson-Brandt
Joseph C. Cappelleri
Xiang Guo
Nabeel Khan
机构：
[1] Swedish Medical Center,Perelman School of Medicine
[2] Brigham and Women’s Hospital,undefined
[3] Pfizer Inc,undefined
[4] Optum Life Sciences,undefined
[5] HEOR,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
[8] University of Pennsylvania,undefined
来源：
BMC Gastroenterology | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis (vol 22, 177, 2022)
    Chiorean, Michael V.
    Allegretti, Jessica R.
    Sharma, Puza P.
    Chastek, Benjamin
    Salese, Leonardo
    Bell, Elizabeth J.
    Peterson-Brandt, Jesse
    Cappelleri, Joseph C.
    Guo, Xiang
    Khan, Nabeel
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [2] Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
    Xiao, Y.
    Lakatos, P. L.
    Bourdages, R.
    Bitton, A.
    Afif, W.
    Kohen, R.
    Berberi, M.
    Bessissow, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S445 - S445
  • [3] Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian Real world
    Parra-Izquierdo, Viviana
    Frias-Ordonez, Juan Sebastian
    Cuadros, Carlos
    Vargas, Melquicedec
    Chamorro, Jose Fernando Vera
    Sanchez, Consuelo Romero
    Florez-Sarmiento, Cristian
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (06): : 574 - 581
  • [4] Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis
    Biron, I. Avni
    Shitrit, A. Bar-Gil
    Koslowsky, B.
    Kopylov, U.
    Levartovsky, A.
    Weisshof, R.
    Aviv-Cohen, N.
    Maharshak, N.
    Hovel, D.
    Naftali, T.
    Goren, I.
    Snir, I.
    Ollech, J.
    Banai, H.
    Lena, B.
    Dotan, I.
    Yanai, H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S498 - S499
  • [5] Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience
    Parra-Izquierdo, Viviana
    Frias-Ordonez, Juan Sebastian
    Marquez, Juan Ricardo
    Juliao-Banos, Fabian
    Galindo, Pablo
    Cuadros, Carlos
    Rojas, Carlos
    Rojas, Nelson
    Ardila, Oscar
    Tovar-Fierro, German
    Garcia-Duperly, Rafael
    Vargas, Melquicedec
    Florez-Sarmiento, Cristian
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (07): : 512 - 521
  • [6] Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
    Honap, Sailish
    Chee, Desmond
    Chapman, Thomas P.
    Patel, Mehul
    Kent, Alexandra J.
    Ray, Shuvra
    Sharma, Esha
    Kennedy, James
    Cripps, Sarah
    Walsh, Alissa
    Goodhand, James R.
    Ahmad, Tariq
    Satsangi, Jack
    Irving, Peter M.
    Kennedy, Nicholas A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (10): : 1385 - 1393
  • [7] REAL-WORLD EXPERIENCE WITH TOFACITINIB DOSE DE-ESCALATION IN PATIENTS WITH MODERATE AND SEVERE ULCERATIVE COLITIS
    Yu, Amy
    Shi, Bingyan
    Ha, Nghiem
    Beck, Kendall
    [J]. GASTROENTEROLOGY, 2023, 164 (04) : S102 - S102
  • [8] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [9] Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis
    Yu, Amy
    Ha, Nghiem B.
    Shi, Bingyan
    Cheng, Yao-Wen
    Mahadevan, Uma
    Beck, Kendall R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (12) : 3115 - +
  • [10] REAL-WORLD EXPERIENCE WITH TOFACITINIB DOSE DE-ESCALATION IN PATIENTS WITH MODERATE AND SEVERE ULCERATIVE COLITIS
    Yu, Amy
    Shi, Bingyan
    Ha, Nghiem
    Beck, Kendall
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 : S80 - S80
12345